Group One Trading, L.P. Mersana Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.54 Billion
Q4 2024

A detailed history of Group One Trading, L.P. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 52,283 shares of MRSN stock, worth $26,141. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,283

Previous 32,570 60.53%

Holding current value

$26,141

Previous $61,000 21.31%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.42 - $2.68 $27,992 - $52,830	19,713 Added 60.53%	52,283 $74,000
Q3 2024 Nov 14, 2024	BUY	$1.23 - $2.25 $11,193 - $20,475	9,100 Added 38.77%	32,570 $61,000
Q2 2024 Aug 14, 2024	BUY	$2.0 - $4.45 $46,940 - $104,441	23,470 New	23,470 $47,000
Q4 2023 Feb 14, 2024	SELL	$1.11 - $2.34 $12,195 - $25,709	-10,987 Reduced 26.12%	31,081 $72,000
Q3 2023 Nov 09, 2023	SELL	$1.06 - $3.91 $125,329 - $462,298	-118,235 Reduced 73.76%	42,068 $53,000
Q2 2023 Aug 09, 2023	BUY	$3.08 - $9.55 $487,268 - $1.51 Million	158,204 Added 7537.11%	160,303 $527,000
Q1 2023 May 12, 2023	BUY	$4.0 - $7.02 $8,396 - $14,734	2,099 New	2,099 $8,000
Q3 2022 Nov 09, 2022	SELL	$4.63 - $8.0 $5,931 - $10,248	-1,281 Reduced 63.32%	742 $5,000
Q2 2022 Aug 11, 2022	SELL	$2.84 - $5.0 $45,724 - $80,500	-16,100 Reduced 88.84%	2,023 $9,000
Q1 2022 May 12, 2022	BUY	$3.74 - $6.63 $62,832 - $111,384	16,800 Added 1269.84%	18,123 $72,000
Q4 2021 Feb 11, 2022	SELL	$5.48 - $9.86 $13,842 - $24,906	-2,526 Reduced 65.63%	1,323 $8,000
Q3 2021 Nov 12, 2021	BUY	$8.56 - $14.47 $32,947 - $55,695	3,849 New	3,849 $36,000
Q2 2021 Aug 10, 2021	SELL	$13.28 - $18.07 $117,793 - $160,280	-8,870 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$15.31 - $26.52 $74,452 - $128,966	4,863 Added 121.36%	8,870 $144,000
Q4 2020 Feb 10, 2021	BUY	$16.84 - $27.59 $67,477 - $110,553	4,007 New	4,007 $107,000

Others Institutions Holding MRSN

# of Institutions

136

Shares Held

101M

Call Options Held

77.2K

Put Options Held

453K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $48.6M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Mersana Therapeutics, Inc. Transaction History